Evidence map›Paper›PMID 38429906›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Blautia Coccoides is a Newly Identified Bacterium Increased by Leucine Deprivation and has a Novel Function in Improving Metabolic Disorders.

Yuguo Niu, Xiaoming Hu, Yali Song, Cunchuan Wang, Peixiang Luo, Shihong Ni, Fuxin Jiao, Ju Qiu, Weihong Jiang, Sheng Yang and 7 more

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Colonic metabolomic and transcriptomic alterations in a mouse model of metabolic syndrome.American journal of physiology. Gastrointestinal and liver physiology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. ΔmSystems · 2026
    Article
  8. Journal for immunotherapy of cancer · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. New Horizons in Metabolic Health: Unveiling the Future of Drug Discovery and Development.Endocrine, metabolic & immune disorders drug targets · 2026
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Yuguo NiuZhongshan Hospital, State Key Laboratory of Medical Neurobiology, Institute for Translational Brain Research, MOE Frontiers Center for Brain Science, Fudan University, Shanghai, 200032, China.
Xiaoming HuZhongshan Hospital, State Key Laboratory of Medical Neurobiology, Institute for Translational Brain Research, MOE Frontiers Center for Brain Science, Fudan University, Shanghai, 200032, China.
Yali SongDepartment of Metabolic and Bariatric Surgery and Clinical Research Institute, First Affiliated Hospital of Jinan University, Guangzhou, 510632, China.
Cunchuan WangDepartment of Metabolic and Bariatric Surgery and Clinical Research Institute, First Affiliated Hospital of Jinan University, Guangzhou, 510632, China.
Peixiang LuoCAS Key Laboratory of Nutrition, Metabolism and Food Safety, Innovation Center for Intervention of Chronic Disease and Promotion of Health, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, 200031, China.
Shihong NiZhongshan Hospital, State Key Laboratory of Medical Neurobiology, Institute for Translational Brain Research, MOE Frontiers Center for Brain Science, Fudan University, Shanghai, 200032, China.
Fuxin JiaoCAS Key Laboratory of Nutrition, Metabolism and Food Safety, Innovation Center for Intervention of Chronic Disease and Promotion of Health, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, 200031, China.
Ju QiuCAS Key Laboratory of Nutrition, Metabolism and Food Safety, Innovation Center for Intervention of Chronic Disease and Promotion of Health, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, 200031, China.
Weihong JiangKey Laboratory of Synthetic Biology, Institute of Plant Physiology and Ecology, CAS Center for Excellence in Molecular Plant Science, Shanghai, 200032, China.
Sheng YangKey Laboratory of Synthetic Biology, Institute of Plant Physiology and Ecology, CAS Center for Excellence in Molecular Plant Science, Shanghai, 200032, China.
Jun ChenKey Laboratory of Synthetic Biology, Institute of Plant Physiology and Ecology, CAS Center for Excellence in Molecular Plant Science, Shanghai, 200032, China.
Rui HuangCAS Key Laboratory of Nutrition, Metabolism and Food Safety, Innovation Center for Intervention of Chronic Disease and Promotion of Health, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, 200031, China.
Haizhou JiangZhongshan Hospital, State Key Laboratory of Medical Neurobiology, Institute for Translational Brain Research, MOE Frontiers Center for Brain Science, Fudan University, Shanghai, 200032, China.
Shanghai ChenZhongshan Hospital, State Key Laboratory of Medical Neurobiology, Institute for Translational Brain Research, MOE Frontiers Center for Brain Science, Fudan University, Shanghai, 200032, China.
Qiwei ZhaiCAS Key Laboratory of Nutrition, Metabolism and Food Safety, Innovation Center for Intervention of Chronic Disease and Promotion of Health, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, 200031, China.
Jia XiaoDepartment of Metabolic and Bariatric Surgery and Clinical Research Institute, First Affiliated Hospital of Jinan University, Guangzhou, 510632, China.
Feifan GuoZhongshan Hospital, State Key Laboratory of Medical Neurobiology, Institute for Translational Brain Research, MOE Frontiers Center for Brain Science, Fudan University, Shanghai, 200032, China.ORCID 0000-0001-6628-7647
Fudan University · CNShanghai Institute of Nutrition and Health · CNCenter for Excellence in Molecular Plant Sciences · CNFirst Affiliated Hospital of Jinan University · CN

Funding

China Postdoctoral Science Foundation 2022M720795National Key Research and Development Program of China 2018YFA0800600National Natural Science Foundation 31830044National Natural Science Foundation 81970742National Natural Science Foundation 82000764National Natural Science Foundation 82170868National Natural Science Foundation 82270905National Natural Science Foundation 82300939National Natural Science Foundation 82300940National Natural Science Foundation 82370811National Natural Science Foundation 91957207National Natural Science Foundation 9235730017Natural Science Foundation of Shanghai "science and technology innovation action plan" 21ZR1475900Shanghai leading talent program
6 · The paper itself

Abstract

Gut microbiota is linked to human metabolic diseases. The previous work showed that leucine deprivation improved metabolic dysfunction, but whether leucine deprivation alters certain specific species of bacterium that brings these benefits remains unclear. Here, this work finds that leucine deprivation alters gut microbiota composition, which is sufficient and necessary for the metabolic improvements induced by leucine deprivation. Among all the affected bacteria, B. coccoides is markedly increased in the feces of leucine-deprived mice. Moreover, gavage with B. coccoides improves insulin sensitivity and reduces body fat in high-fat diet (HFD) mice, and singly colonization of B. coccoides increases insulin sensitivity in gnotobiotic mice. The effects of B. coccoides are mediated by metabolizing tryptophan into indole-3-acetic acid (I3AA) that activates the aryl hydrocarbon receptor (AhR) in the liver. Finally, this work reveals that reduced fecal B. coccoides and I3AA levels are associated with the clinical metabolic syndrome. These findings suggest that B. coccoides is a newly identified bacterium increased by leucine deprivation, which improves metabolic disorders via metabolizing tryptophan into I3AA.

Indexed as

Disease Models, AnimalGastrointestinal MicrobiomeLeucineMice, Inbred C57BLAnimalsDiet, High-FatEubacterialesFecesHumansIndoleacetic AcidsInsulin ResistanceMaleMetabolic DiseasesMiceTryptophanIndoleacetic AcidsLeucineTryptophanaryl hydrocarbon receptorblautia coccoidesgut microbiotaindole‐3‐acetic acidleucine deprivation

Identifiers

PMID38429906
PMCPMC11095201
OpenAlexW4392345919

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.